Tscan Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $194k | 33k | 5.83 |
| 2022-03-31 | $1.0k | 361 | 2.77 |